The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Decibel Therapeutics, Inc(NASDAQ:DBTX) 
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to...
Share this website to your friends
Decibel Therapeutics Days Receivable Outstanding ttm (DSO)
Decibel Therapeutics Op Cashflow Per Share ttm
Decibel Therapeutics Free Cashflow Per Share ttm
Decibel Therapeutics Cash Per Share ttm
Decibel Therapeutics P/S ratio ttm
Decibel Therapeutics (GAAP) P/E ratio ttm
Decibel Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.